Canada Pension Plan Investment Board
DYN icon

Canada Pension Plan Investment Board’s Dyne Therapeutics DYN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-284,000
Closed -$5.56M – 1779
2025
Q4 		$5.56M Hold
284,000
– – ﹤0.01% 759
2025
Q3 		$3.59M Buy
+284,000
New +$3.24M ﹤0.01% 808

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Canada Pension Plan Investment Board's DYN Position: Q1 2026 in Review

Canada Pension Plan Investment Board sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 284,000 shares — an estimated $5.56M sold.

Canada Pension Plan Investment Board first reported a position in DYN in Q3 2025 and held it in 2 quarters. The position peaked at $5.56M in Q4 2025. 228 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Canada Pension Plan Investment Board reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 284,000 Dyne Therapeutics shares in Q1 2026, an estimated $5.56M.
  • Canada Pension Plan Investment Board first reported a position in Dyne Therapeutics in Q3 2025 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Dyne Therapeutics position peaked at $5.56M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.